State Minister Diana Gamage stated that the Cabinet had sanctioned the cultivation of cannabis for export purposes, citing its potential use in medicine. The announcement, was made when questioned by journalists as she arrived for the new parliamentary session.
The revelation by Minister Gamage about the Cabinet's alleged approval for cannabis cultivation for medicinal export has sparked debates and concerns within the public sphere.
However, Cabinet Spokesperson Minister Bandula Gunawardena has contradicted this claim, stating that no such proposal was discussed or approved during the last cabinet meeting.
The apparent discrepancy between Minister Gamage's statement and Minister Gunawardena's denial has further fueled the controversy surrounding this issue.
The legalization and regulation of cannabis cultivation for medicinal purposes is a contentious topic globally, with proponents arguing for its potential health benefits and economic opportunities, while opponents raise concerns about substance abuse and regulatory challenges.
In Sri Lanka, where conservative attitudes towards drug policy prevail, the prospect of legalizing cannabis cultivation for export raises significant ethical, legal, and public health considerations. The conflicting statements from government officials only serve to deepen the uncertainty surrounding this issue.
As the debate unfolds, stakeholders, including lawmakers, medical professionals, civil society organizations, and the public, will be expecting clarity and accountability from the government regarding its stance on cannabis cultivation and its purported approval process.
The revelation by Minister Gamage about the Cabinet's alleged approval for cannabis cultivation for medicinal export has sparked debates and concerns within the public sphere.
However, Cabinet Spokesperson Minister Bandula Gunawardena has contradicted this claim, stating that no such proposal was discussed or approved during the last cabinet meeting.
The apparent discrepancy between Minister Gamage's statement and Minister Gunawardena's denial has further fueled the controversy surrounding this issue.
The legalization and regulation of cannabis cultivation for medicinal purposes is a contentious topic globally, with proponents arguing for its potential health benefits and economic opportunities, while opponents raise concerns about substance abuse and regulatory challenges.
In Sri Lanka, where conservative attitudes towards drug policy prevail, the prospect of legalizing cannabis cultivation for export raises significant ethical, legal, and public health considerations. The conflicting statements from government officials only serve to deepen the uncertainty surrounding this issue.
As the debate unfolds, stakeholders, including lawmakers, medical professionals, civil society organizations, and the public, will be expecting clarity and accountability from the government regarding its stance on cannabis cultivation and its purported approval process.
Latest News
Australian doctor dies after world-first brain tumour treatment
Local
07 June 2026
Airlines cut 2026 profit outlook as Iran war drives fuel surge
Local
07 June 2026
Zelenskiy in UK for talks with Starmer
Local
07 June 2026
Iran threatens retaliation after Beirut attack
Local
07 June 2026
Former SIS chief admitted to Colombo National Hospital
Local
07 June 2026
Iranian court upholds jail term, travel ban for Jafar Panahi
Local
07 June 2026
Olivia Rodrigo debuts new album featuring Robert Smith duet
Local
07 June 2026
Iran's World Cup team arrive in Tijuana
Local
07 June 2026
Iran assets will stay frozen until peace deal is reached
Local
07 June 2026
Israel strikes Gaza as Egypt leads new ceasefire talks
Local
07 June 2026